PD-L1 is a Prognostic Biomarker in Resected NSCLC Patients with Moderate/high Smoking History and Elevated Serum SCCA Level

Lianjing Cao(Sun Yat-sen University), Richeng Jiang(Tianjin Medical University Cancer Institute and Hospital)
Journal of Cancer
January 1, 2017
Cited by 24


Related Papers